Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Amdocs (DOX) Q3 Earnings Match Estimates
Amdocs (DOX) Q3 Earnings Match Estimates

Amdocs (DOX) came out with quarterly earnings of $1.84 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.72 per share a year ago. These figures are adjusted for

Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates
Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $1.6 per share a year ago. These figures

Corpay (CPAY) Q2 Earnings and Revenues Beat Estimates
Corpay (CPAY) Q2 Earnings and Revenues Beat Estimates

Corpay (CPAY) came out with quarterly earnings of $7 per share, beating the Zacks Consensus Estimate of $6.6 per share. This compares to earnings of $5.13 per share a year ago. These figures are

Clearfield (CLFD) Beats Q3 Earnings Estimates
Clearfield (CLFD) Beats Q3 Earnings Estimates

Clearfield (CLFD) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.11 per share a year ago. These figures

Central Garden (CENTA) Tops Q3 Earnings and Revenue Estimates
Central Garden (CENTA) Tops Q3 Earnings and Revenue Estimates

Central Garden (CENTA) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.56 per share a year ago. These

Central Garden (CENT) Surpasses Q3 Earnings and Revenue Estimates
Central Garden (CENT) Surpasses Q3 Earnings and Revenue Estimates

Central Garden (CENT) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.56 per share a year ago. These

AppLovin (APP) Tops Q2 Earnings Estimates
AppLovin (APP) Tops Q2 Earnings Estimates

AppLovin (APP) came out with quarterly earnings of $3.76 per share, beating the Zacks Consensus Estimate of $3.72 per share. This compares to earnings of $2.26 per share a year ago. These figures

Axon Enterprise (AXON) Q2 Earnings Miss Estimates
Axon Enterprise (AXON) Q2 Earnings Miss Estimates

Axon Enterprise (AXON) came out with quarterly earnings of $1.88 per share, missing the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $2.12 per share a year ago. These

Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates
Arcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates

Arcutis Biotherapeutics, Inc. (ARQT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to a loss of $0.13 per share a year

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $0.46 per share a year ago. These

Curaleaf Holdings, Inc. (CURLF) Q2 Earnings and Revenues Surpass Estimates
Curaleaf Holdings, Inc. (CURLF) Q2 Earnings and Revenues Surpass Estimates

Curaleaf Holdings, Inc. (CURLF) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.2 per share. This compares to a loss of $0.18 per share a

Cirrus Logic (CRUS) Q1 Earnings Surpass Estimates
Cirrus Logic (CRUS) Q1 Earnings Surpass Estimates

Cirrus Logic (CRUS) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.8 per share. This compares to earnings of $1.51 per share a year ago. These

Barrett Business Services Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Barrett Business Services Q2 Earnings Call Highlights

Key Points

Amtech Systems Q3 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Amtech Systems Q3 Earnings Call Highlights

Key Points

Arcutis Biotherapeutics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Retail store, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/5574eb69-dc38-42f3-aadd-6163ac8bd4a8.png
Arcutis Biotherapeutics Q2 Earnings Call Highlights

Key Points

AppLovin Q2 Earnings Call Highlights
AppLovin Q2 Earnings Call Highlights

Key Points

Alto Ingredients Q2 Earnings Call Highlights
Alto Ingredients Q2 Earnings Call Highlights

Key Points

Akebia Therapeutics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Akebia Therapeutics Q2 Earnings Call Highlights

Key Points

Airgain Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.theapi.app/temp/bee95973-d201-429b-849e-52867059bd1a.png
Airgain Q2 Earnings Call Highlights

Key Points

ADMA Biologics Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Specialty food store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/7a8f69d5-c26e-46d9-b403-d3e5e9562eca.png
ADMA Biologics Q2 Earnings Call Highlights

Key Points